BioClonetics has created a monoclonal antibody (called Clone 3) that specifically targets and effectively neutralizes HIV. We expect this antibody to provide the first therapeutic cure for HIV.

Detail information is at www.bioclonetics.com. A funding profile is linked here: https://www.fundable.com/bioclonetics-immunotherapeutics-inc

Highlights are: Lab tested and proven, recombinant antibody being produced, and animal trials scheduled.